This analysis examines AI-driven protein design advancements, comparing North American and European strategies, with added insights on Asian initiatives. It…
European Startups Advance Circular Economy with Biotech and AI Innovations
This article analyzes how European startups, including Twogee Biotech with its €2.16M seed funding, are using biotech and AI to…
Female Founders in Europe Secure Record Funding in Tech Surge
In 2025, female entrepreneurs across Europe are driving innovation with substantial funding in AI, biotech, and quantum computing, enhancing diversity…
FDA Unveils New Pathway for Personalized Gene-Editing Therapies
The FDA’s new regulatory framework for personalized gene-editing therapies, leveraging AI and data analytics, aims to scale treatments for ultra-rare…
AI Advances Personalized Medicine and Cuts Drug Development Costs
Artificial intelligence is transforming medicine by enabling personalized therapies and reducing drug development expenses from over $2.6 billion per drug.…
Europe’s deep tech surge in quantum and biotech secures future innovations
European startups LuxQuanta and Tubulis lead in quantum security and biotechnology, with recent funding enhancing data protection and cancer treatments…
AI-Powered Health Tech Investments Soar in Europe
European health tech companies raised $13.9 billion in Q1 2025, driven by AI innovations in mental health and biotechnology, signaling…
How European deep tech like turbine is solving AI’s drug discovery problem
Budapest-based Turbine’s Simulated Cell platform tackles target validation, a core challenge where most AI drug discovery startups fail, earning validation…
NUCLIDIUM’s €84M boost positions Europe at forefront of precision cancer therapy
European biotech NUCLIDIUM secured €84M Series B funding to advance copper-based radiopharmaceutical cancer treatments, highlighting Europe’s precision medicine leadership through…
OpenAI Debuts Autonomous AI Researchers Capable of Designing Nuclear and Pathogen Experiments
OpenAI’s new o3/o4-mini models autonomously design scientific experiments, disrupting R&D economics while raising ethical questions about AI-driven discovery in sensitive…
AI transforms niche drug discovery for heart and metabolic diseases
AI is revolutionizing drug discovery for heart conditions and metabolic diseases, with companies like CardiaTec and Multiomic Health leading the…
AI-powered drug discovery accelerates in Europe with Isomorphic Labs leading the charge
Isomorphic Labs announces plans for clinical trials of AI-designed drugs, with European startups and big pharma collaborations reshaping drug development.…